GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
142,032,675
Share change
+10,229,283
Total reported value
$985,856,098
Put/Call ratio
73%
Price per share
$6.94
Number of holders
165
Value change
+$68,387,497
Number of buys
73
Number of sells
78

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2024

As of 30 Sep 2024, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 142,032,675 shares. The largest 10 holders included Francisco Partners Management, LP, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, Rubric Capital Management LP, MILLENNIUM MANAGEMENT LLC, AMERICAN CENTURY COMPANIES INC, T. Rowe Price Investment Management, Inc., LAKEWOOD CAPITAL MANAGEMENT, LP, Silver Lake Group, L.L.C., and RENAISSANCE TECHNOLOGIES LLC. This page lists 163 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.